Insights

Get access to our latest news by becoming an Avulux Authorized Provider.

Patient CareMigraine Affects One In Every Five Of The Patients

Migraine Affects One In Every Five Of The Patients You’ll See Today. Are You Ready To Help Them?

As an ECP, of course you’re focused on supporting your patients’ vision and eye health. But did you know that you can also help patients who experience migraine and light sensitivity – and that thi...

Apr 22, 2024
Patient CareHero

Why Prescribing Avulux Migraine Lenses is a Win-Win for Patients and Your Practice

There are many great reasons to prescribe Avulux Migraine Light Sensitivity lenses through your practice – it’s a novel sub-specialty, it’s easy to implement, and it provides an opportunity to expa...

Feb 29, 2024
Case StudyPhotograph of Dr. Julie Helmus, Owner Of Helmus Optometry In Davis, California

Dr. Julie Helmus: 3 Reasons Why Avulux Is a Game-Changer for Her Patients and Practice

As an optometrist who constantly searches for ways to drive her business forward, rise above the competition, and offer more complete care to her patients, Dr. Julie Helmus knew she wanted to add A...

Dec 1, 2023

White Glove Onboarding

Dedicated Avulux representatives are available to enable you and your team

Trusted by Over 1,400 ECPs

There are over 1,400 Avulux Authorized Providers globally

Ongoing Support & Resources

Avulux providers have access to our team and a suite of tools to help you better serve your patients

Over 50,000

Over 50,000 Avulux wearers are managing the impact of light on their lives.

Become an
Avulux Provider

Become an Avulux Provider

Indications for Use: Avulux® is an FDA-authorized, over-the-counter precision optical filter indicated to block light at 480 nm (high blue range) and 590 nm (red/amber range), while allowing light in the remaining visible color spectrum through, to decrease the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older. The use of Avulux should not alter the usual care therapy of patients diagnosed with episodic migraine, including medication usage.

Avulux is intended to be used as an adjunct to usual care for migraine, including medication. It is not intended to diagnose, treat, cure, or prevent migraine or any other disease and is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare professional regarding migraine symptoms and treatment. Avulux is classified by the U.S. Food and Drug Administration as a Class I medical device under 21 CFR § 882.5811, product code QEO. De Novo request DEN250026.